Incannex Healthcare (IXHL) Income from Continuing Operations (2022 - 2026)
Incannex Healthcare's (IXHL) quarterly Income from Continuing Operations came in at 3883000.0 in Q1 2026, up 2.14% year-on-year from 3801565.26 in Q1 2025, and up 40.45% quarter-over-quarter from 6521000.0 in Q4 2025.
Incannex Healthcare (IXHL) Income from Continuing Operations (2022 - 2026) Analysis & Trends
Incannex Healthcare has disclosed Income from Continuing Operations across 5 years of filings, most recently posting 3883000.0 for Q1 2026.
- Income from Continuing Operations for Q1 2026 came in at 3883000.0, up 2.14% year-over-year; the trailing twelve-month figure through Mar 2026 was 48414000.0 (down 122.97% YoY), and the FY2025 annual result was 46885000.0, down 154.0% from the prior year.
- Income from Continuing Operations came in at 3883000.0 for Q1 2026 at Incannex Healthcare, up from 6521000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 726000.0 in Q3 2023 to a low of 31603000.0 in Q2 2025.
- The 5-year median for Income from Continuing Operations is 5330500.0 (2023), against an average of 6627714.29.
- Across the five-year window, Income from Continuing Operations slumped 646.56% in 2024 and surged 34.21% in 2025, its largest moves.
- Incannex Healthcare's Income from Continuing Operations stood at 2918000.0 in 2022, then slumped by 79.61% to 5241000.0 in 2023, then fell by 12.46% to 5894000.0 in 2024, then decreased by 10.64% to 6521000.0 in 2025, then soared by 40.45% to 3883000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 3883000.0 (Q1 2026), 6521000.0 (Q4 2025), and 6407000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 370.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 601.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 274.90 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 21.05 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 197.90 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -66.53 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -92.12 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 118.42 Mn |
| 10 | Incannex Healthcare | 45.81 Mn | 45.81 Mn | - | -3.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.88 Mn |
| Dec 31, 2025 | -6.52 Mn |
| Sep 30, 2025 | -6.41 Mn |
| Jun 30, 2025 | -31.60 Mn |
| Mar 31, 2025 | -3.97 Mn |
| Dec 31, 2024 | -5.89 Mn |
| Sep 30, 2024 | -5.42 Mn |
| Jun 30, 2024 | -6.43 Mn |
| Mar 31, 2024 | -6.03 Mn |
| Dec 31, 2023 | -5.24 Mn |
| Sep 30, 2023 | -726,000.00 |
| Jun 30, 2023 | -4.17 Mn |
| Mar 31, 2023 | -3.57 Mn |
| Dec 31, 2022 | -2.92 Mn |